GCP
IMNN icon

GSA Capital Partners’s Imunon IMNN Stock Holding History

GSA Capital Partners’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-680
Closed -$72K – 1596
2021
Q4 		$72K Buy
680
+553
+435% +$86.1K 0.01% 1334
2021
Q3 		$23K Buy
+127
New +$26.4K ﹤0.01% 1360
2021
Q1 		– Sell
-1,363
Closed -$190K – 1279
2020
Q4 		$190K Buy
1,363
+558
+69% +$66.9K 0.03% 1007
2020
Q3 		$115K Buy
+805
New +$203K 0.02% 1110

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

GSA Capital Partners's IMNN Position: Q1 2022 in Review

GSA Capital Partners sold out of Imunon (IMNN) in Q1 2022, closing a stake of 680 shares — an estimated $72K sold.

GSA Capital Partners first reported a position in IMNN in Q3 2020 and held it in 4 quarters. The position peaked at $190K in Q4 2020. 23 funds tracked by Wall St. Rank hold IMNN as of Q1 2022.

  • GSA Capital Partners reported no remaining Imunon position as of Q1 2022 after selling out during the quarter.
  • GSA Capital Partners sold 680 Imunon shares in Q1 2022, an estimated $72K.
  • GSA Capital Partners first reported a position in Imunon in Q3 2020 and held it in 4 quarters.
  • GSA Capital Partners's Imunon position peaked at $190K in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q1 2022.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.